495 related articles for article (PubMed ID: 32684527)
1. Fasting serum total bile acid levels are associated with insulin sensitivity, islet β-cell function and glucagon levels in response to glucose challenge in patients with type 2 diabetes.
Wang XH; Xu F; Cheng M; Wang X; Zhang DM; Zhao LH; Cai HL; Huang HY; Chen T; Zhang XL; Wang XQ; Cheng XB; Su JB; Lu Y
Endocr J; 2020 Nov; 67(11):1107-1117. PubMed ID: 32684527
[TBL] [Abstract][Full Text] [Related]
2. Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes.
Wang H; Cao J; Su JB; Wang XQ; Wang X; Zhang DM; Wang XH
Diabetol Metab Syndr; 2021 Jun; 13(1):70. PubMed ID: 34174950
[TBL] [Abstract][Full Text] [Related]
3. Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function.
Chen X; Maldonado E; DeFronzo RA; Tripathy D
J Clin Endocrinol Metab; 2021 Apr; 106(5):1398-1409. PubMed ID: 33524152
[TBL] [Abstract][Full Text] [Related]
4. Inverse relationship between serum adenosine deaminase levels and islet beta cell function in patients with type 2 diabetes.
Cao J; Wang H; Su JB; Wang XQ; Zhang DM; Wang XH; Liu WS; Ge XQ
Diabetol Metab Syndr; 2021 May; 13(1):54. PubMed ID: 34001220
[TBL] [Abstract][Full Text] [Related]
5. Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area.
Fujita Y; Kozawa J; Iwahashi H; Yoneda S; Uno S; Yoshikawa A; Okita K; Eguchi H; Nagano H; Imagawa A; Shimomura I
Endocr J; 2015; 62(4):329-37. PubMed ID: 25740613
[TBL] [Abstract][Full Text] [Related]
6. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
Li X; Zhou ZG; Qi HY; Chen XY; Huang G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
[TBL] [Abstract][Full Text] [Related]
7. Serum total bile acids associate with risk of incident type 2 diabetes and longitudinal changes in glucose-related metabolic traits.
Zhu W; Wang S; Dai H; Xuan L; Deng C; Wang T; Zhao Z; Li M; Lu J; Xu Y; Chen Y; Wang W; Bi Y; Xu M; Ning G
J Diabetes; 2020 Aug; 12(8):616-625. PubMed ID: 32220107
[TBL] [Abstract][Full Text] [Related]
8. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S
Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU
Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037
[TBL] [Abstract][Full Text] [Related]
10. Relationship between circadian blood pressure variability and function of islet α and β cell in type 2 diabetes with dyssomnia.
Ren HZ; Zheng MY; Shan CY; Yang JH; Xu YG; Yang YH; Wang Y; Chen LM; Chang BC
J Diabetes Complications; 2015 Jul; 29(5):675-8. PubMed ID: 25957006
[TBL] [Abstract][Full Text] [Related]
11. Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.
Taha DR; Castells S; Umpaichitra V; Bastian W; Banerji MA
J Pediatr Endocrinol Metab; 2002 Jan; 15(1):59-67. PubMed ID: 11822582
[TBL] [Abstract][Full Text] [Related]
12. Comparison of islet cell function, insulin sensitivity, and incretin axis between Asian-Indians with either impaired fasting glucose or impaired glucose tolerance, and normal healthy controls.
Roy A; Kamalanathan S; Sahoo J; Kar SS; Naik D; Narayanan N; Merugu C; Patel D
Diabetes Res Clin Pract; 2021 Jun; 176():108846. PubMed ID: 33951481
[TBL] [Abstract][Full Text] [Related]
13. Increased serum cystatin C levels and responses of pancreatic α- and β-cells in type 2 diabetes.
Yuan HQ; Miao JX; Xu JP; Zhu SX; Xu F; Wang XH; Wang CH; Yu C; Wang XQ; Su JB; Zhang DM
Endocr Connect; 2022 Mar; 11(3):. PubMed ID: 35179515
[TBL] [Abstract][Full Text] [Related]
14. Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin.
Wewalka M; Patti ME; Barbato C; Houten SM; Goldfine AB
J Clin Endocrinol Metab; 2014 Apr; 99(4):1442-51. PubMed ID: 24432996
[TBL] [Abstract][Full Text] [Related]
15. Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis.
Mezza T; Moffa S; Ferraro PM; Quero G; Capece U; Carfì A; Cefalo CMA; Cinti F; Sorice GP; Impronta F; Mari A; Pontecorvi A; Alfieri S; Holst JJ; Giaccari A
J Clin Endocrinol Metab; 2019 Jul; 104(7):2685-2694. PubMed ID: 30874733
[TBL] [Abstract][Full Text] [Related]
16. Vildagliptin added to metformin on β-cell function after a euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetes patients.
Derosa G; Ragonesi PD; Carbone A; Fogari E; Bianchi L; Bonaventura A; Romano D; Cicero AF; Maffioli P
Diabetes Technol Ther; 2012 Jun; 14(6):475-84. PubMed ID: 22512264
[TBL] [Abstract][Full Text] [Related]
17. Low-Density Lipoprotein Cholesterol Is Associated With Insulin Secretion.
Dannecker C; Wagner R; Peter A; Hummel J; Vosseler A; Häring HU; Fritsche A; Birkenfeld AL; Stefan N; Heni M
J Clin Endocrinol Metab; 2021 May; 106(6):1576-1584. PubMed ID: 33693827
[TBL] [Abstract][Full Text] [Related]
18. Serum Amylase Levels in Relation to Islet β Cell Function in Patients with Early Type 2 Diabetes.
Zhuang L; Su JB; Zhang XL; Huang HY; Zhao LH; Xu F; Chen T; Wang XQ; Wu G; Wang XH
PLoS One; 2016; 11(9):e0162204. PubMed ID: 27606813
[TBL] [Abstract][Full Text] [Related]
19. Utility of C-peptide for a reliable estimate of insulin secretion in children with growth hormone deficiency.
Ciresi A; Cicciò F; Radellini S; Giordano C
Growth Horm IGF Res; 2016 Aug; 29():71-77. PubMed ID: 27235725
[TBL] [Abstract][Full Text] [Related]
20. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
Kruszynska YT; Goulas S; Wollen N; McIntyre N
J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
